Skip to main content
Department of Industrial Pharmacy

Researches The department research plan participates in solving problems that face the pharmaceutical industry in the vicinity of Asyut City and others. Staff members are also supervising and teaching post-graduate students, Diploma, MSc. and Ph.D. students, and the proposed advanced and novel specializations in pharmaceutical sciences for the next 5 years plan listed below: Targeted drug delivery using Micro-/Nan particulate technologies (Polymeric particles, micro-emulsions, liposomes, etc.) Enhancing peptide and protein drug delivery via the oral and pulmonary routes. Controlled release formulation of drugs. Enhancing drug dissolution and bioavailability. Gastro-retentive technology. Transdermal drug delivery.

# Title Research Year
31 Different cellulosic polymers for synthesizing silver nanoparticles with antioxidant and antibacterial activities 2021
32 In Vitro Characterization of Inhalable Cationic Hybrid Nanoparticles as Potential Vaccine Carriers 2021
33 Ultra-small lipid nanoparticles encapsulating sorafenib and midkine-siRNA selectively-eradicate sorafenib-resistant hepatocellular carcinoma in vivo 2021
34 Silver Nanoparticle-Coated Ethyl Cellulose Inhibits Tumor Necrosis Factor-α of Breast Cancer Cells 2021
35 Studying the Complex Formation of Sulfonatocalix[4]naphthalene and Meloxicam towards Enhancing Its Solubility and Dissolution Performance 2021
36 Pharmaceutical, clinical, and immunohistochemical studies of metformin hydrochloride topical hydrogel for wound healing application 2020
37 Combining acetyl salicylic acid and rofecoxib into novel oral tablets normalize platelet function with potential higher tolerability in patients with cardiovascular disorders 2020
38 Lipid Nanoparticles for Cell-Specific in Vivo Targeted Delivery of Nucleic Acids 2020
39 Enhancing the Low Oral Bioavailability of Sulpiride
via Fast Orally Disintegrating Tablets: Formulation,
Optimization and In Vivo Characterization
2020
40 Fluorescent Nanoparticles Coated with a Somatostatin Analogue
Target Blood Monocyte for Efficient Leukaemia Treatment
2020